Skip to main content
VCbacked
Log inGet Started

MicroTransponder

Dallas, United States

MicroTransponder is a medical device company that develops and commercializes neurostimulation devices to treat neurological diseases.

$65.0M raised
Mar 2025
Series F
Health CareMedicalMedical Device

Top Investors

U.S. Venture PartnersLongitude CapitalOUP (Osage University Partners)Gilde HealthcareAction Potential Venture Capital

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about MicroTransponder

How much funding has MicroTransponder raised?
MicroTransponder has raised $65.0M in total funding. The most recent round was Series F. The last funding was announced in March 2025.
Who are MicroTransponder's investors?
MicroTransponder's investors include U.S. Venture Partners, Longitude Capital, OUP (Osage University Partners), Gilde Healthcare, Action Potential Venture Capital.
Where is MicroTransponder headquartered?
MicroTransponder is headquartered in Dallas, United States.
What does MicroTransponder do?
MicroTransponder is a medical device company that develops and commercializes neurostimulation devices to treat neurological diseases.
What stage is MicroTransponder at?
MicroTransponder is at the Series F stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"MicroTransponder — Funding & Investors." VCBacked, March 12, 2025, https://www.vcbacked.co/company/microtransponder. Accessed June 17, 2026.
APA
VCBacked. (2025). MicroTransponder — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/microtransponder
Wikipedia (cite web)
{{cite web |title=MicroTransponder — Funding & Investors |url=https://www.vcbacked.co/company/microtransponder |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Health Care

View all
Virtuoso Surgical
Nashville
Basata
Phoenix
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Sedivention
Munich$848K